Realising the next generation of PCR diagnostics

ML 3+1About Enigma

Enigma Diagnostics is taking PCR-based testing out of the laboratory with a range of simple-to-use products.

Enigma Technology

Proprietary technology providing the next generation of integrated and automated real-time PCR-based diagnostics.

Enigma Instruments

The Enigma ML provides fully integrated and automated raw sample to result, real-time PCR diagnostic testing for laboratories, local hospitals, at point-of-care locations.

New Expert Review

The Enigma ML FluAB-RSV assay: a fully automated molecular test for the rapid detection of influenza A, B and respiratory syncytial viruses in respiratory specimens.

Simon D Goldenberg, Jonathan D Edgeworth, Expert Review of Molecular Diagnostics Jan 2015, Vol. 15, 23-32. View Article

Press Releases:
Enigma Diagnostics Signs Joint Venture Agreement with Beijing Leadman Biochemistry and Announces US$50 Million Investment
22nd October 2014
Enigma Diagnostics and China’s ICDC Announce Collaboration to Develop MDx Infectious Disease Assays on Enigma ML system for use at Point-of-Care
15th May 2014
Enigma Diagnostics Secures Additional Technology Strategy Board Funding for Multi-Drug Resistant Tuberculosis Assay
11th March 2014
View all Press Releases
See us at:

Daytona Beach, FL - Booth 401

Apr 26-28

Copenhagen, Denmark

Apr 25-28